AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Return On Equity

Annual ROE:

-100.88%-113.61%(-892.46%)
December 31, 2024

Summary

  • As of today, AMLX annual return on equity is -100.88%, with the most recent change of -113.61% (-892.46%) on December 31, 2024.
  • During the last 3 years, AMLX annual ROE has risen by +87.17% (+46.35%).
  • AMLX annual ROE is now -230.05% below its all-time high of 77.57%, reached on December 31, 2019.

Performance

AMLX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXprofitability metrics

Quarterly ROE:

-94.60%+0.71%(+0.74%)
June 1, 2025

Summary

  • As of today, AMLX quarterly return on equity is -94.60%, with the most recent change of +0.71% (+0.74%) on June 1, 2025.
  • Over the past year, AMLX quarterly ROE has dropped by -49.13% (-108.05%).
  • AMLX quarterly ROE is now -841.96% below its all-time high of 12.75%, reached on December 31, 2023.

Performance

AMLX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

AMLX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-892.5%-108.0%
3Y3 Years+46.4%-8.2%
5Y5 Years-230.1%+41.2%

AMLX ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-892.5%+46.4%-842.0%+14.4%
5Y5-Year-230.1%+87.3%-842.0%+88.8%
All-TimeAll-Time-230.1%+87.3%-842.0%+88.8%

AMLX ROE History

DateAnnualQuarterly
Jun 2025
-
-94.60%(+0.7%)
Mar 2025
-
-95.31%(+12.8%)
Dec 2024
-100.88%(-892.5%)
-109.32%(-37.7%)
Sep 2024
-
-79.41%(-74.6%)
Jun 2024
-
-45.47%(-145.0%)
Mar 2024
-
-18.56%(-245.6%)
Dec 2023
12.73%
12.75%(+2176.8%)
Sep 2023
-
0.56%(+102.2%)
Jun 2023
-
-25.70%(+56.1%)
DateAnnualQuarterly
Mar 2023
-
-58.60%(+40.5%)
Dec 2022
-92.53%(+50.8%)
-98.54%(+10.8%)
Sep 2022
-
-110.53%(-26.4%)
Jun 2022
-
-87.47%(-46.7%)
Mar 2022
-
-59.62%(+18.9%)
Dec 2021
-188.05%(+76.3%)
-73.47%(+91.3%)
Jun 2021
-
-843.86%(-94.8%)
Mar 2021
-
-433.11%(-169.0%)
Dec 2020
-792.21%(-1121.3%)
-160.99%
Dec 2019
77.57%
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual return on equity?
  • What is the all-time high annual ROE for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual ROE year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly ROE year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual return on equity?

The current annual ROE of AMLX is -100.88%

What is the all-time high annual ROE for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual return on equity is 77.57%

What is Amylyx Pharmaceuticals, Inc. annual ROE year-on-year change?

Over the past year, AMLX annual return on equity has changed by -113.61% (-892.46%)

What is Amylyx Pharmaceuticals, Inc. quarterly return on equity?

The current quarterly ROE of AMLX is -94.60%

What is the all-time high quarterly ROE for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly return on equity is 12.75%

What is Amylyx Pharmaceuticals, Inc. quarterly ROE year-on-year change?

Over the past year, AMLX quarterly return on equity has changed by -49.13% (-108.05%)
On this page